Wittenberg Investment Management, Inc. Pfizer Inc Transaction History

Wittenberg Investment Management, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$30.12 - $36.54 $250,236 - $303,574	-8,308 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $24,597 - $35,144	-910 Reduced 9.87%	8,308 $271,000
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $14,978 - $16,998	-455 Reduced 4.7%	9,218 $361,000
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $14,782 - $19,169	-455 Reduced 4.49%	9,673 $348,000
Q2 2019 Jul 24, 2019	SELL	$36.98 - $41.52 $29,842 - $33,506	-807 Reduced 7.38%	10,128 $439,000
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $28,890 - $32,938	-751 Reduced 6.43%	10,935 $477,000
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $10,444 - $12,668	-303 Reduced 2.53%	11,686 $515,000
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $31,910 - $37,020	-1,000 Reduced 7.7%	11,989 $425,000
Q4 2017 Feb 12, 2018	SELL	$33.26 - $35.29 $5,055 - $5,364	-152 Reduced 1.16%	12,989 $470,000
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $407,371 - $448,765	13,141	13,141 $469,000

3,261

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Wittenberg Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Wittenberg Investment Management, Inc. with notifications on news.